Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study

scientific article published on 11 February 2019

Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CAM4.2018
P932PMC publication ID6488117
P698PubMed publication ID30741477

P50authorHuaqiang ZhouQ47168899
Li ZhangQ88393467
Zhonghan ZhangQ89390017
Wei XianQ89416223
Gang ChenQ89416228
Shaodong HongQ89862803
Yaxiong ZhangQ90221819
Jiayi ShenQ91264564
Wenfeng FangQ96167057
Jianhua ZhanQ117259063
Hongyun ZhaoQ117259064
P2093author name stringXi Chen
Yan Huang
Ting Zhou
Yuanyuan Zhao
Yuxiang Ma
Xue Hou
Yunpeng Yang
Jiaqing Liu
Shen Zhao
P2860cites work‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*Q22066036
Lung cancer in never smokers: clinical epidemiology and environmental risk factorsQ24598433
Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer TherapyQ26773056
Mendelian randomization studies: a review of the approaches used and the quality of reportingQ26999349
Cancer statistics, 2018.Q47191906
Very long-chain n-3 fatty acids and human health: fact, fiction and the futureQ47642249
Anti-proliferative effects of a new docosapentaenoic acid monoacylglyceride in colorectal carcinoma cellsQ47815272
Lung cancer death rates in lifelong nonsmokers.Q51804779
Polyunsaturated fatty acids and risk of melanoma: A Mendelian randomisation analysis.Q52688932
Metabolome-wide association study identified the association between a circulating polyunsaturated fatty acids variant rs174548 and lung cancer.Q53049091
The MR-Base platform supports systematic causal inference across the human phenome.Q55427190
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease StudyQ56669882
Lung Cancer Risk Reduction After Smoking Cessation: Observations From a Prospective Cohort of WomenQ61670391
Multistage carcinogenesis and lung cancer mortality in three cohortsQ81748599
Dietary patterns in association to cancer incidence and survival: concept, current evidence, and suggestions for future researchQ88125530
A prospective study of dietary polyunsaturated fatty acids intake and lung cancer riskQ89112347
Docosapentaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3), is a potent stimulator of endothelial cell migration on pretreatment in vitroQ28647096
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancerQ28943461
Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE ConsortiumQ30431111
A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomizationQ31156212
The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathwayQ33634757
Polyunsaturated fatty acid intake and risk of lung cancer: a meta-analysis of prospective studiesQ33748784
Usefulness of Mendelian randomization in observational epidemiologyQ33858805
Large upward bias in estimation of locus-specific effects from genomewide scansQ34044873
Smoking cessation and lung cancer risk in an Asian population: Findings from the Singapore Chinese Health StudyQ34250055
Mendelian randomization: prospects, potentials, and limitationsQ34312296
Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylationQ35389104
Dietary sources, current intakes, and nutritional role of omega-3 docosapentaenoic acidQ35742951
Tobacco Cessation May Improve Lung Cancer Patient SurvivalQ35828404
Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signalingQ36001468
The LLP risk model: an individual risk prediction model for lung cancerQ36614749
Marine polyunsaturated fatty acids and cancer therapyQ36671846
Multi-targeted therapy of cancer by omega-3 fatty acidsQ36947010
Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort studyQ36974431
Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation studyQ37045787
Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimatorsQ37197630
Commentary: Two-sample Mendelian randomization: opportunities and challengesQ37219780
Docosapentaenoic acid (22:5n-3): a review of its biological effects.Q37775276
Fish consumption and lung cancer risk: systematic review and meta-analysisQ38202669
Dietary PUFA and cancerQ38213622
Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysisQ38614073
Short update on docosapentaenoic acid: a bioactive long-chain n-3 fatty acidQ38710850
Interpreting findings from Mendelian randomization using the MR-Egger methodQ38773596
ω-3 polyunsaturated fatty acids inhibit the proliferation of the lung adenocarcinoma cell line A549 in vitroQ39054899
Fluoxetine potentiation of omega-3 fatty acid antidepressant effect: evaluating pharmacokinetic and brain fatty acid-related aspects in rodentsQ39137169
Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortiumQ39524941
Docosahexaenoic Acid Induces Cell Death in Human Non-Small Cell Lung Cancer Cells by Repressing mTOR via AMPK Activation and PI3K/Akt InhibitionQ40574345
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median EstimatorQ40773355
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regressionQ40862437
Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.Q43668998
The polyunsaturated fatty acids, EPA and DPA exert a protective effect in the hippocampus of the aged rat.Q45340302
Inhibition of platelet aggregation by omega-3 polyunsaturated fatty acids is gender specific-Redefining platelet response to fish oils.Q45989791
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectpolyunsaturated fatty acidQ2005087
Mendelian randomizationQ6816584
P304page(s)1817-1825
P577publication date2019-02-11
P1433published inCancer MedicineQ27724564
P1476titleDocosapentaenoic acid and lung cancer risk: A Mendelian randomization study
P478volume8